Use of low-dose erythropoietin for stimulation of endothelial progenitor cells, for organ regeneration and for slowing the progression of end-organ damage

Details for Australian Patent Application No. 2010200621 (hide)

Owner EPOplus GmbH & Co. KG

Inventors Bahlmann, Ferdinand Hermann; Haller, Hermann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010200621

Parent 2005205917

Filing date 19 February 2010

Wipo publication date 11 March 2010

International Classifications

A61K 8/64 (2006.01) Cosmetics or similar toilet preparations

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61Q 1/00 (2006.01) Make-up preparations

A61Q 7/00 (2006.01) Preparations for affecting hair growth

A61Q 17/00 (2006.01) Barrier preparations

A61Q 19/00 (2006.01) Preparations for care of the skin

A61Q 19/08 (2006.01) Preparations for care of the skin - Anti-ageing preparations

Event Publications

4 March 2010 Complete Application Filed

11 March 2010 Application Open to Public Inspection

  Published as AU-A-2010200621

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200622-Safety device for emergency interruption of the drilling maneuvers

2010200620-Polypeptides